[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200000736A1 - Фармацевтические композиции - Google Patents

Фармацевтические композиции

Info

Publication number
EA200000736A1
EA200000736A1 EA200000736A EA200000736A EA200000736A1 EA 200000736 A1 EA200000736 A1 EA 200000736A1 EA 200000736 A EA200000736 A EA 200000736A EA 200000736 A EA200000736 A EA 200000736A EA 200000736 A1 EA200000736 A1 EA 200000736A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
cyclopenten
purin
cyclopropylamino
cis
Prior art date
Application number
EA200000736A
Other languages
English (en)
Other versions
EA002916B1 (ru
Inventor
Никки Тоуннз Брукс
Original Assignee
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксо Груп Лимитед filed Critical Глаксо Груп Лимитед
Publication of EA200000736A1 publication Critical patent/EA200000736A1/ru
Publication of EA002916B1 publication Critical patent/EA002916B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям (1S,4R)-цис-4-[2-амино-6-(циклопропиламино)-9H-пурин-9-ил]-2-циклопентен-1-метанола (1592U89).Отчет о международном поиске был опубликован 1999.10.28.
EA200000736A 1998-02-06 1999-02-04 Фармацевтические композиции EA002916B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802472.2A GB9802472D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en) 1998-02-06 1999-02-04 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
EA200000736A1 true EA200000736A1 (ru) 2001-04-23
EA002916B1 EA002916B1 (ru) 2002-10-31

Family

ID=10826520

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000736A EA002916B1 (ru) 1998-02-06 1999-02-04 Фармацевтические композиции

Country Status (39)

Country Link
US (1) US6641843B1 (ru)
EP (1) EP1051156B1 (ru)
JP (1) JP3560550B2 (ru)
KR (1) KR100564854B1 (ru)
CN (2) CN1296406A (ru)
AP (1) AP1212A (ru)
AR (1) AR017455A1 (ru)
AT (1) ATE237309T1 (ru)
AU (1) AU754255B2 (ru)
BR (1) BR9907649A (ru)
CA (1) CA2319010C (ru)
CO (1) CO5070673A1 (ru)
CZ (1) CZ299608B6 (ru)
DE (1) DE69906934T2 (ru)
DK (1) DK1051156T3 (ru)
EA (1) EA002916B1 (ru)
EE (1) EE04217B1 (ru)
ES (1) ES2196779T3 (ru)
GB (1) GB9802472D0 (ru)
HK (1) HK1030552A1 (ru)
HR (1) HRP20000530B1 (ru)
HU (1) HU228315B1 (ru)
ID (1) ID26215A (ru)
IL (2) IL137403A0 (ru)
IS (1) IS2200B (ru)
MA (1) MA26604A1 (ru)
MY (1) MY121043A (ru)
NO (1) NO329041B1 (ru)
NZ (1) NZ505811A (ru)
PE (1) PE20000271A1 (ru)
PL (1) PL194558B1 (ru)
PT (1) PT1051156E (ru)
RS (1) RS49953B (ru)
SI (1) SI1051156T1 (ru)
SK (1) SK284397B6 (ru)
TR (1) TR200002293T2 (ru)
TW (1) TWI222878B (ru)
WO (1) WO1999039691A2 (ru)
ZA (1) ZA99890B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2305680A3 (en) * 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567703A (en) 1988-01-20 1996-10-22 Regents Of The University Of Minnesota Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
IL127350A0 (en) * 1996-06-25 1999-10-28 Glaxo Group Ltd Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
US6124319A (en) * 1997-01-21 2000-09-26 Merck & Co., Inc. 3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6177464B1 (en) * 1997-03-14 2001-01-23 Sepracor, Inc. Ring opening metathesis of alkenes
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt

Also Published As

Publication number Publication date
MA26604A1 (fr) 2004-12-20
SK284397B6 (sk) 2005-03-04
CZ299608B6 (cs) 2008-09-17
AP2000001878A0 (en) 2000-09-30
IL137403A (en) 2007-07-24
ES2196779T3 (es) 2003-12-16
PE20000271A1 (es) 2000-04-17
SK11682000A3 (sk) 2001-04-09
CN1296406A (zh) 2001-05-23
BR9907649A (pt) 2000-10-31
AU2722199A (en) 1999-08-23
HRP20000530A2 (en) 2001-02-28
HUP0100802A3 (en) 2001-12-28
CN101239063A (zh) 2008-08-13
GB9802472D0 (en) 1998-04-01
WO1999039691A3 (en) 1999-10-28
CA2319010C (en) 2008-06-10
EP1051156A2 (en) 2000-11-15
KR20010040714A (ko) 2001-05-15
AP1212A (en) 2003-11-12
ATE237309T1 (de) 2003-05-15
IS2200B (is) 2007-02-15
IS5569A (is) 2000-07-20
EP1051156B1 (en) 2003-04-16
DE69906934T2 (de) 2004-02-12
ZA99890B (en) 2000-08-04
PL194558B1 (pl) 2007-06-29
NO20003962D0 (no) 2000-08-04
AR017455A1 (es) 2001-09-05
EE200000459A (et) 2002-02-15
IL137403A0 (en) 2001-07-24
YU48200A (sh) 2003-02-28
KR100564854B1 (ko) 2006-03-30
DK1051156T3 (da) 2003-06-23
JP3560550B2 (ja) 2004-09-02
NO329041B1 (no) 2010-08-02
JP2002502808A (ja) 2002-01-29
HK1030552A1 (en) 2001-05-11
US6641843B1 (en) 2003-11-04
TWI222878B (en) 2004-11-01
NO20003962L (no) 2000-09-27
CA2319010A1 (en) 1999-08-12
PL342628A1 (en) 2001-06-18
HRP20000530B1 (en) 2003-10-31
DE69906934D1 (de) 2003-05-22
EA002916B1 (ru) 2002-10-31
HU228315B1 (en) 2013-03-28
RS49953B (sr) 2008-09-29
ID26215A (id) 2000-12-07
MY121043A (en) 2005-12-30
PT1051156E (pt) 2003-09-30
SI1051156T1 (en) 2003-08-31
CZ20002867A3 (cs) 2001-02-14
EE04217B1 (et) 2004-02-16
CO5070673A1 (es) 2001-08-28
HUP0100802A2 (hu) 2001-08-28
NZ505811A (en) 2002-09-27
TR200002293T2 (tr) 2000-11-21
WO1999039691A2 (en) 1999-08-12
AU754255B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
PT1032374E (pt) Esferoides processo de preparacao e composioes farmaceuticas
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
EP0980864A3 (en) Sulphonamide derivatives
CO4940435A1 (es) Sal de hemisulfato del (1s,4r)-cis-4-[2-amino-6- (ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol o un solvato del mismo
EA200000736A1 (ru) Фармацевтические композиции
EP1100497A4 (en) HETEROCYCLYL SULFAMIDE DERIVATIVES
BRPI9916820B8 (pt) composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método
SE9604582D0 (sv) Novel compounds
BG102229A (en) Endothelium receptor antagonists
ECSP992846A (es) Composiciones farmaceuticas
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
WO1998034949A3 (en) Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
IT1303556B1 (it) Procedimento di preparazione di composti del tipoarilamminoalchilidenemalonati.
SE9803277D0 (sv) Novel compounds
GT199800008A (es) Procedimiento para la preparacion de un derivado de tetrahidropiridina.
UA16247A1 (ru) N-(3-хлоро-1,4-нафтохинонил-2)-2-d,l-аспарагиновая кислота, которая проявляет кардиостимулирующие свойства

Legal Events

Date Code Title Description
ND4A Extension of term of a eurasian patent
MK4A Patent expired

Designated state(s): AM AZ BY KG MD TJ TM RU